The results of monitoring of pregnant women with hypertension against the background of pharmacotherapy. A comparative evaluation of the clinical efficacy of treatment of hypertension in pregnancy, the drug metoprolol tartrate (Egilok retard, Egis, Hungary) and methyldopa (dopegit, Egis, Hungary). The positive effect of metoprolol tartrate in pregnant women with hypertension in the kidney, heart, psychological profile, as well as safety for the fetus. Purpose:To evaluate the psychological profile of pregnant women with essential hypertension on antihypertensive therapy. The method and methodology of work: We observed 43 pregnant women with pre-existing hypertension of pregnancy. Surveyed women were divided into 2 groups by open randomized trial. The first group was assigned to metoprolol tartrate (Egilok retard) at a dose of 50-75 mg / day, once in monotherapy, the second - methyldopa (dopegit) at a daily dose of 500-1000 mg as a single agent. The first group included women aged 24 to 40 years, mean age was 30,1 ± 4,15 years, the second from 23 to 36 years with a mean age of 28,5 ± 3,55 years. The groups were matched for age, presence of somatic diseases, gynecological diseases, the presence of harmful habits. The area of ​​application of the results: medicine.